The resident begins their PGY2 training year with a 6 week department and residency orientation. This orientation includes EPIC training, medication preparation training, and orientation to the Stem Cell Clinic pharmacist role. Throughout the year, residents will complete six (6) required learning experiences, each focused on a site-specific cancer types. Longitudinal experiences are completed intermittently throughout the 12 month program. Additionally, residents have the opportunity to choose an elective learning experiences or repeat a required rotation in an advanced format.
Required 7-Week Learning Experience in Site-Specific Cancers:
- Lymphoma/Multiple Myeloma/Autologous Stem Cell Transplant
- Leukemia/Allogenic Stem Cell Transplant
- Breast/GYN Cancers
- Lung/Head and Neck Cancers
- GI/GU Cancers
- Hematology Disorders and Other Cancers
Longitudinal Learning Experiences (12 Months):
- Management
- Investigational Drug Service
- Teaching
- Staffing
- Research Project
Residency Program Completion Requirements
For successful completion of this PGY2 Oncology pharmacy residency program, signified with the awarding of a certificate of achievement at the end of the 12-month period, the resident must successfully complete the following program requirements and comply with Baptist Memphis policies for employment.
Criteria include:
- TN State licensure by the predetermined deadline established each calendar year.
- Compliance with standards established for ALL Baptist-Memphis employees with no disciplinary action requiring termination.
- Completion of all required, assigned hospital and department employee competencies
- "Satisfactory" completion of all required longitudinal education assignments as defined in the description for each activity in the residency manual
- Journal Club x6, ACPE accredited continuing education x2, Clinical writing assignments, Medication Use Evaluation x1, Drug Monograph x1
- "Satisfactory" completion of a residency research project including IRB approval, data collection, presentation of the conclusion with proposed changes to the associated staff and development of a final manuscript suitable for publication.
- Completion of all required and elective learning and longitudinal experiences
- Documentation of achieved for residency (“ACHR”) on 75% of the required & selected elective ASHP competency objectives as evaluated in learning experiences and longitudinal experiences by the end of the 12 month residency. The required number of “ACHs” needed per objective to obtain “ACHR” will be provided each year to the resident during orientation
- Active participation in the University of Tennessee Teaching and Learning Program including student precepting and presentation of a didactic lecture
- Membership and participation in BCC oversight committees including Medication Management Committee Oncology Protocol Review Committee
- Attendance at Tennessee Oncology Pharmacist Association Annual Meeting (Fall) and Hematology/Oncology Pharmacy Association Annual Meeting (Spring)
- Completion of all PharmAcademic evaluations
- Maintain ALL documents relating to projects, longitudinal activities & presentations in the resident’s electronic folder on the Shared Drive. Complete Resident End of the Year Checklist.
Baptist Cancer Center Oncology PGY2 Resident
Residents in our PGY2 pharmacy residency program have already completed a PGY1 residency after graduating with a Doctor of Pharmacy degree, and have continued their learning to specialize in hematological and oncological patient needs.
Baptist Cancer Center PGY2 Clinical Preceptors
Our residents are provided the opportunity to learn from clinical and pharmacy preceptors who have expansive educational backgrounds and specialized experience to enrich their learning and hands-on experiences.
